+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiac Marker Testing"

Cardiac Biomarkers Testing Global Market Report 2024 - Product Thumbnail Image

Cardiac Biomarkers Testing Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
Global Diagnostics Labs Market Outlook, 2029 - Product Thumbnail Image

Global Diagnostics Labs Market Outlook, 2029

  • Report
  • January 2024
  • 163 Pages
  • Global
From
From
From
From
Loading Indicator

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence. Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events. Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more